Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PeptiDreamPPTDF 81 3-Year Book Growth Rate is 17.30% as of Jun. 2026, which is 18% below its 10-year median of 21.00. GuruFocus rates PPTDF with a GF Score™ of 81/100 and a GF Value™ of $5.99 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 1,128 Biotechnology companies, PeptiDream ranks better than 82.98% on this metric.
During the past 12 months, PeptiDream's average Book Value per Share Growth Rate was -9.10% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 17.30% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 22.00% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 20.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of PeptiDream was 172.60% per year. The lowest was 15.40% per year. And the median was 21.00% per year.
PeptiDream (OTCPK:PPTDF) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
PeptiDream 3-Year Book Growth Rate Related Terms
PPTDF vs VRTX, REGN, MRNA: 3-Year Book Growth Rate Comparison
For the Biotechnology subindustry, PeptiDream's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PeptiDream 3-Year Book Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PeptiDream's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where PeptiDream's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 17.30% mean?
PeptiDream (PPTDF) has a 3-Year Book Growth Rate of 17.30% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for PeptiDream and its competitors. This is 18% below median its historical median of 21.00. Over the past decade, PeptiDream's 3-Year Book Growth Rate has ranged from 15.40 to 172.60. According to the industry distribution chart, PeptiDream ranks #192 out of 1128 companies in the Biotechnology industry, placing it in the top 17%.
Is PeptiDream's 3-Year Book Growth Rate too high?
PeptiDream's current 3-Year Book Growth Rate of 17.30% is 18% below median its 10-year median of 21.00. Over the past 10 years, this metric has ranged from a low of 15.40 to a high of 172.60. Based on the distribution chart, PeptiDream ranks #192 out of 1128 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, PeptiDream has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PeptiDream's 3-Year Book Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PeptiDream ranks #192 out of 1128 companies for 3-Year Book Growth Rate. This places PeptiDream in the top 17% of its industry — outperforming the majority of peers. Historically, PeptiDream's own 3-Year Book Growth Rate has ranged from 15.40 to 172.60 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Biotechnology company?
A good 3-Year Book Growth Rate depends on the Biotechnology industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for PeptiDream and its competitors. PeptiDream's current 3-Year Book Growth Rate is 17.30%, which is 18% below median its own 10-year median of 21.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PeptiDream stock overvalued right now?
Based on GuruFocus' analysis, PeptiDream (PPTDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $5.99, compared to a current price of $7.00 — trading 16.9% above its estimated fair value. The current 3-Year Book Growth Rate is 17.30%, which is 18% below median its 10-year median of 21.00. PeptiDream's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For PeptiDream (PPTDF), the current 3-Year Book Growth Rate is 17.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PeptiDream (PPTDF) Overvalued in 2026?
Based on GuruFocus' analysis, PeptiDream stock appears to be overvalued.
The current stock price of $7.00 is trading 16.9% above its estimated GF Value™ of $5.99.
GuruFocus considers PeptiDream to be Modestly Overvalued.
Key valuation signals for PPTDF:
3-Year Book Growth Rate: 17.30% (18% below median its 10-year median of 21.00)
GF Value™: $5.99 vs. price of $7.00 (16.9% above fair value)
No single metric tells the full story. See the PPTDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PeptiDream Inc is engaged in the drug discovery and development business. The group utilizes PDPS, its proprietary drug discovery and development platform system, for drug discovery and development, and it conducts radiopharmaceutical business through a wholly owned subsidiary and is involved in the research, development, and manufacturing of pharmaceuticals, etc. Its reportable segments are Drug discovery and development business and Radiopharmaceutical business.
81GF Score
Get the complete analysis for PPTDF
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PPTDF has been successfully added to your 
